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Background: Many studies have found a substantial minority of patients whose performance puts them
within the normal range of neuropsychological functioning. Recently, a study has seen the delineation of
two neurocognitive subtypes of schizophrenia –‘cognitively normal range’ (CNR) and ‘below normal
range’ (BNR) – based on neurocognitive performance across multiple domains.
Methods: The participantswere from two studies that collected neurocognitive, psychopathology and social
function data between 2008 and 2015. In total the complete data from one hundred and thirty one patients
of Han Chinese ethnicity with schizophrenia were collected on 21 neurocognitive indexes (assessing the
domains of processing speed, attention, working memory, verbal memory, visual memory, reasoning and
problem solving and IQ). Fifty-ﬁve patients of the one hundred and thirty one participants received addi-
tional ratings on their psychopathology and social functions. An exploratory graphic analysis was conduct-
ed on the neurocognitive measures for the entire sample. Difference analyses were also performed
according to the aims of the study using the Independent t test, Chi-square test, and Cohen's d effect size.
Results: Analyses revealed the existence of two patients subtypes. The post hoc tests showed that there
were signiﬁcant differences on all of their neurocognitive measures and on most of the psychopathology
and social functions between the two subtypes. These two subtypes could be referred to as the CNR subtype
and the BNR subtype respectively.
Conclusions: There are neurocognitive subtypes of schizophrenia with differential illness characteristics
comparable with the CNR and the BNR in patients of Han Chinese ethnicity with schizophrenia.
©2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Schizophrenia is a devastating and chronic neuropsychiatric dis-
order that affects nearly 1% of the world's population (Dhindsa and
Goldstein 2016). Much of the evidence shows that cognitive deﬁcits
in schizophrenia are heterogeneous, ranging from pervasive general-
ized dysfunction through patchy focal disorders to mild focal deﬁcitsng and Clinical Psychology,
d., Shoufeng, Hualien 97401,
300.
hiang),
ail.com (C.-P. Tsai),
.N
T
fe
li. This is an open access article undor nearly normal performance (Chapman and Chapman 1989; Gould
et al. 2014; Elliott and Sahakian 1995; Jæger et al. 2003; Badcock et al.
2005; Nuechterlein et al. 2004; Wilk et al. 2005). In addition, evi-
dence from cross-sectional (Green 1996; Harvey et al. 1998; Leung
et al. 2008) and longitudinal studies (Green et al. 2004) has consis-
tently shown that cognitive impairment in schizophrenia is a more
stable and robust correlate of functional impairment than clinical
symptoms. Because the ultimate aim of cognitive enhancement is to
support functional recovery, cases where neuropsychological (NP)
performance is normal may lead to these cases being regarded as
having minimal intervention potential (Leung et al. 2008). In the
study by Leung et al. (2008), they found that NP normal cases still
show deﬁcits in several domains of everyday functioningmilestones.
Hence, they thought the classiﬁcations of NP normalitymay provide a
meaningful categorization for the concept of outcome in the recovery
model. In addition, a population-representative longitudinal study
found that NP normal cases showed a decline on the digit symboler the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ture of schizophrenia (Meier et al. 2014). These results suggest that
identiﬁcation of NP normality could reduce the likelihood of false
negative judging in their outcomes. Recently, Heinrichs et al. (2015)
validated two neurocognitive subtypes of schizophrenia using the
MATRICS Consensus Cognitive Battery (MCCB), for which the criteria
for assignment to cognitively normal range (CNR) groupswere based
on previous studies using MCCB (Kern et al. 2004, 2011; Muharib
et al. 2014).CNR schizophrenia patients may be largely indistinguish-
able from normal-range controls, with the exception of processing
speed performance. In contrast with CNR, below normal range
(BNR) may be indistinguishable from low-performing controls even
in terms of processing speed.
Based on the ﬁndings of the aforementioned studies, it is reason-
able that we hypothesize the same neurocognitive subtypes of
schizophrenia with differential illness characteristics in patients of
Han Chinese ethnicity with schizophrenia. Unfortunately, we could
not ﬁnd any published empirical papers to examine this hypothesis.
The aim of this study was to validate the CNR and BNR subtypes in
chronically hospitalized patients with schizophrenia.
2. Materials and methods
2.1. Participants
The sample came from two studies. From one part of the sample,
76 subjects were recruited from a study on cognitive impairment in
stable, hospitalized patients with schizophrenia (the Cognitive Func-
tion study), whereas from another part of the sample, 55 subjects
were recruited from a study on the follow-up of mental functions in
stable, hospitalized patientswith schizophrenia (theMental Function
study). The criteria of inclusion and exclusion of the subjectswere the
same in both studies. In total, 131 patients of Han Chinese ethnicity
with schizophrenia, aged 20–65, who had been diagnosed according
to the criteria of the Diagnostic and Statistical Manual of Mental Dis-
orders, Fourth Edition (DSM-IV) participated in this study. Subjects
were excluded from this study if their scores on the Mini Mental Sta-
tus Examination (MMSE) were below 20, if they refused to receive
the evaluation or had an acute psychotic episode that required trans-
fer for admission, or if they had the presence of an organic brain dis-
order, brain injury with post-traumatic amnesia, mental retardation,
movement disorders, or recent (within 6 months) substance depen-
dence or electroconvulsive therapy.
2.2. Measures
Six cognitive domains according to MATRICS-NIMH suggestions
about the fundamental dimensions of cognitive deﬁcit in schizophre-
nia (Nuechterlein et al. 2004) were included in this study. The sev-
enth cognitive domain, IQ, suggested by Genderson et al. (2007),
was also included. In addition, to judge if a patient's basic cognitive
function was qualiﬁed as a subject for taking various tests reliably
in this study, we also administered a screen test.
We selected the tests for measuring seven different cognitive do-
mains, and we constructed them by referencing the suggestions and
the results in Nuechterlein et al. (2004). The ﬁnal results of the test
selection in this study were:1) the Speed of Processing: the Digit
Symbol Substitution Test (DSS) in the Chinese Version of the
Wechsler Adult Intelligence Test, Third Version (CV-WAIS-III) (Chen
and Chen 2002) and the A Form and the B Form of the Trial Making
Test (TMA & TMB) (Lezak et al. 2004); 2) the Attention: the Conners
Continuous Performance Test, 3rd Edition (Conners CPT 3) (Conners
2014); 3) theWorkingMemory: theWorkingMemory Index (WMI)
in the CV-WAIS-III; 4) the Verbal Memory: the Logistic Memory Test
(LG) in the Chinese Version of the Wechsler Memory Test, ThirdVersion (CV-WMS-III) (Hwa et al. 2005); 5) the Visual Memory: the
Visual Reproduction (VR) Test in the CV-WMS-III; 6) Reasoning and
Problem Solving: the Modiﬁed Card Sorting Test (MCST) (Nelson
1976) and the Semantic Associated Verbal Fluency Test (SAVFT)
(Hwa 1999); 7) the Full-Scaled IQ (FSIQ),which is a short-formversion
of the CV-WAIS-III composed of four subtests including the Informa-
tion, the Arithmetic, the Digit Span, and the Block Design (Chiang
et al. 2007). The basic cognitive functionwas assessedwith the Chinese
version (Guo et al. 1988) of the Mini-Mental State Examination
(MMSE) (Folstein et al. 1975). A total of 21measured cognitive indexes
were used as variables for the partitioning of neurocognitive subtypes.
Psychopathology was assessed with the Chinese version (Cheng
et al. 1996) of the Positive and Negative Syndrome Scale (CV-
PANSS) (Kay et al. 1987). Regarding social function, the Chinese ver-
sion of the Social Function Scale (CV-SFS) was used to assess the
seven dimensions of the social function of subjects including with-
drawal, interpersonal, independence-competence, independence-
performance, pro-social, recreation, and employment (Song 2001).
2.3. Rating of NP impairment
Because there is no Chinese version of the MCCB in Taiwan, we
could not follow the criteria for assignment to CNR and BNR, as was
followed in the study by Heinrichs et al. (2015). We reviewed three
strategies for the designation of impairment in the study of
Reichenberg et al. (2009): the Individual Proﬁle Rating (IPR) proce-
dure presented by Kremen et al. (2000), the deﬁnition of Clinically
Signiﬁcant Cognitive Impairment (CSCI) suggested by Palmer et al.
(1997), and the Global Deﬁcit Score (GDS) approach adopted by
Heaton et al. (2004) and Carey et al. (2004). We decided to use the
GDS method as the criterion for validating the CNR and BNR accord-
ing to the ﬁndings of previous studies, including: 1) the IPR was less
sensitive to impairment (Reichenberg et al. 2009); 2) the GDS and
CSCI criteria had substantial to outstanding convergence across all di-
agnostic groups (Reichenberg et al. 2009); and 3) the GDS method
was relatively unaffected by modiﬁcations in test batteries (Heaton
et al. 2004; Carey et al. 2004).
The GDS method begins by converting T scores to deﬁcit scores
that reﬂect the presence and severity of impairment. T scores greater
than 40 represented no impairment (deﬁcit score = 0), whereas a
deﬁcit score of 1 reﬂects mild impairment (T scores=39to 35), a def-
icit score of 2 reﬂects mild to moderate impairment (T scores =34 to
30), a deﬁcit score of 3 reﬂects moderate impairment (T scores =29
to 25), a deﬁcit score of 4 reﬂects moderate to severe impairment
(T scores =24 to 20), and a deﬁcit score of 5 reﬂects severe impair-
ment (T scores b20). Deﬁcit scores on all tests were then averaged
to create the GDS. Results in Heaton et al. (2004) and Carey et al.
(2004) showed that a GDS greater than or equal to 0.5 has accurately
predicted the expert clinical rating of overall impairment. In this
study, we adopted GDS 0.5 to be the cutoff of NP impairment.
2.4. Procedures
The Cognitive Function study began in September 2013 and was
completed in August 2015. The study was approved by the Institu-
tional Review Board of the Kaohsiung Municipal Kai-Syuan Psychiat-
ric Hospital. All subjects were screened and veriﬁed by meeting the
study criteria of two professionals with extensive experience in clin-
ical practice and research (CSK, Ph.D., and LKC, M.Sc., both of whom
are certiﬁed clinical psychologists). All neurocognitive function in-
dexes were examined by two qualiﬁed clinical psychologists (NCH
and TCP, both M.Sc.).
TheMental Function study began in July 2008 andwas completed
in June 2013. This study was approved by the Yuli Branch of the
Taipei Veterans General Hospital Institutional Review Board. All
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one professionalwith extensive experience in clinical practice and re-
search (CJY, M.D., certiﬁed psychiatrist). All neurocognitive function
indexes were examined by one qualiﬁed clinical psychologist (CSK.,
Ph.D.). The psychopathology was rated by two certiﬁed psychiatrists
(CJY and PLY). The inter-rater reliability for the CV-PANSS (k=0.85)
was established for both raters. The CV-SFS scores were provided by
senior nurses who were in charge of the subjects, both of whom
have received the required training for the CV-SFS from CSK before
the study had begun. Written informed consent was obtained after
the procedures were fully explained to the patients.2.5. Statistical analysis
2.5.1. Generalized association plot (GAP)
We used GAP to explore the neurocognitive subtypes in 131 pa-
tients with schizophrenia. The GAP (Chen 1996, 1998, 1999; Lin
et al. 1998) is an information visualization environment (http://gap.
stat.sinica.edu.tw.autorpa.tcu.edu.tw) for extracting important infor-
mation embedded in a raw data matrix and proximity matrices for
variables as well as for subjects. Although factor analysis and cluster
analysis are corresponding conventional statistical tools, respectively,
to the GAP correlationmatrix map and the Euclidean distancematrix
map, there is no counterpart for the GAP data matrix map, which is
the most important and unique feature of GAP. Factor analysis de-
pends on a sophisticated statistical model to summarize information
in the correlation matrix, but GAP merely utilizes the sorted correla-
tion matrix map to reveal similar messages. The major difference is
that GAP displays the whole correlation matrix and the raw data ma-
trix without sacriﬁcing any information (Hwu et al. 2002). There
were two reasons we used the GAP in this study. First, the GAP pro-
vides ﬁve levels of integral information, and three matrix maps are
integrated to retrieve these ﬁve levels of information. Second, Hwu
et al. (2002) showed the usefulness of the GAP method in sub-
grouping Han Chinese ethnicity schizophrenic patients based on
their PANSS ratings and clustering symptom-dimensions based on
their relative PANSS scoring structure on admission. We believe
that the rationale of the GAP method is also suitable for partitioning
patients into subgroups according to their neurocognitive functions
in the same social and cultural context.2.5.2. Other statistical analyses
The Statistical Package for the Social Sciences (SPSS) was used for
other statistical analyses. The Independent t test was used to test the
differences in means, and the chi-square test was used to test the dif-
ferences in frequencies between groups in the sample for individual in-
dexes. The signiﬁcance level for a two-sided test was set at α= 0.05.
For comparing seven cognitive domains with norms of normal con-
trols, we computed Cohen's d effect size (Cohen 1988) for differences
between each patient group's mean scores across individual indexes
and cognitive domains. In addition, for validating the CNR and BNR in
the sample, we also computed the GDS of each patient's group.3. Results
3.1. Gap
Fig. 1 shows the order of 21 cognitive function indexes and two
visible dark red blocks along themain diagonal of a correlationmatrix
map. When the patients' relationship structures represented by the
Euclidean distance matrix were sorted, two blocks along the main
diagonal were identiﬁed visually as Group 1 (54 cases) and Group 2
(77 cases).3.2. Demographics, clinical characteristics, and description of individualized
cognitive measures
The left-hand columns of Table 1 show the original data of the de-
mographic features and the means and standard deviations from 21
cognitive function indexes of two groups sorted by the GAP. Except
for gender (x2 = 0.34, p N .05), education (t =−1.01, p N .05) and
CPTd (t= 0.38, p N .05), there were signiﬁcant differences between
Group 1 and Group 2 in Age (t=2.21, p b .05) and all other cognitive
function indexes including MCST p (t = 5.69, p b .001), TMB (t =
17.73, p b .001), TMA (t = 7.89, p b .001), CPTp (t = 3.54, p b .01),
LGTII (t = −3.13, p b .01), LGT (t = −3.70, p b .001), LGII (t =
−3.83, p b .001), LGI (t = −5.00, p b .001), SAVFT (t = −5.63,
p b .001), VRI (t=−3.99, p b .001), VRII (t=−4.43, p b .001), DSS
(t=−5.07, p b .001), MCSTc (t=−7.44, p b .001), BD (t=−5.92,
p b .001), WMI (t=−9.01, p b .001), DS (t=−6.98, p b .001), ARI
(t =−8.22, p b .001), FSIQ (t = −9.25, p b .001), INF (t = −6.89,
p b .001), and MMSE (t=−7.70, p b .001).
To verify whether the proﬁles of the neurocognitive function of
Group 1 and Group 2 are comparable with the CNR and BNR of pa-
tients with schizophrenia, we transformed the original data in the
left-hand columns into the Z-scores data presented in the right-
hand columns of Table 1 by calculating adequate normal Taiwanese
adult norms. The right-hand columns of Table 1 show the Z-score
data of themeans and standard deviations from21 cognitive function
indexes of two groups sorted by the GAP. Similarly, except for (t =
−.47, p N .05), there were signiﬁcant differences between Group 1
and Group 2 in all other neurocognitive function indexes.
Fig. 2 shows the recognizable proﬁles of neurocognitive function be-
tween Group 1 and Group 2. The right-hand columns of Table 1 further
revealedZ scoreswith signiﬁcant differences betweenCNRandBNR. For
CNR, the absolute values of Z scores ranged from 0.34 of CPTd to1.29 of
TMa, compared with Z scores of BNR from 0.26 of CPTd to 4.78 of
MCSTp. Because the higher scores on MSCTp, TBa, TBb, CPTp indicated
worse performance, we reversed the values of these indexes in Fig. 2
for the purpose of comparisons between CNR and BNR from an impair-
ment view. Table 1 and Fig. 2 support Group 1 andGroup 2 in this study
and were comparable with CNR and BNR, respectively.
3.3. Description of social function, psychopathology, and other
clinical features
Table 2 shows the original data of thedemographic features and the
mean and standard deviations of clinical features, psychopathology,
and social function of this sample. Therewere no signiﬁcant differences
on gender (x2 = 2.64, p N .05), Age(t = −.22, p N .05), duration of
illness(t=−1.78, p N .05), chlorpromazine equivalents (CPZE) (t=
0.62, pN .05), negative symptoms (t=0.56, p N .05), general symptoms
(t=−.56, p N .05), CV-PANSS (t=−.99, p N .05), and interpersonal
(t = 1.82, p N .05) between CNR and BNR. CNR was later than BNR
on age at ﬁrst onset (t = 2.39, p b .05), education (t = 3.76,
p b .001), withdrawal score (t = 2.71, p b .01), independence-
competence score (t = 3.37, p b .01), independence-performance
score (t= 4.33, p b .001), recreation score (t = 4.05, p b .001), pro-
social score (t = 3.23, p b .01), employment score (t = 3.99,
p b .001), and CV-SFS score (t= 4.32, p b .001). BNR was higher than
CNR on positive symptoms (t=−2.39, p b .05).
In comparison with the CNR, the BNR patients were older, and
have an earlier illness onset, an increased severity of positive symp-
toms, and a greater severity of functional disability. According to
the Taiwanese Schizophrenic Norms of CV-SFS, the scores of CV-SFS
can be divided into four levels, reﬂecting the patient's level of social
function. Scores above 71 are superior, with scores ranging from 70
to 52 being high, scores ranging from 51 to34 being middling, and
scores below 33 being low. In this study, CNR with a mean score of
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Fig. 1. Clustering of neurocognitive functions and schizophrenic patients using the generalized association plots (GAP). The proximity of between cognitive function correlation co-
efﬁcients for 21 cognitive functions indexes is displayed as a color map in the upper ﬁgure. One hundred and thirty-one patients were ordered and displayed by GAP based on the
matrix of between-patient Euclidean distance in the lower right ﬁgure. Two groups of patients were identiﬁed with their within-group distances summarized in a clustering tree.
The Cognitively Normal Range (CNR) contains ﬁfty-four patients and the Below Normal Range (BNR) contains seventy-seven patients. The raw cognitive functions data for 131
schizophrenic patients with 21 indexes were permuted using the aforementioned respective orders for cognitive functions and for patents, and then displayed as a color map in
the lower left ﬁgure. The complete structure of cognitive functions and patients subgroups together with their interactions was jointly comprehended through visualization.
31S.-K. Chiang et al. / Schizophrenia Research: Cognition 5 (2016) 28–3457.8 was at a high level, while in contrast, BNR with a mean score of
38.31 was in the middle level of social function.
3.4. Validation of CNR and BNR by Cohen's d effect size and the GDS
3.4.1. Cohen's d effect size of cognitive indexes and cognitive domains
For BNR patients, the effect sizes ranged from d = 0.29 to 2.26
across the16 individual indexes and from 1.12 to 2.39 across the
seven cognitive domains. For CNR patients, the resulting effect sizes
ranged from d = 0.02 to 1.01 across the 16 individual indexes and
from 0.18 to 0.93 across the seven cognitive domains. Fig. 3 reveals
the effect sizes pooled root mean square according to the cognitive
domains across the two groups of patients.
3.4.2. The GDS
The same cognitive indexes were used to compute the GDS as
were used to compute Cohen's d effect size. For BNR patients, T scores
ranged from T = 2.2 to 52.6 across the 16 individual indexes. One
cognitive index had deﬁcit scores of 0, ﬁve indexes had deﬁcit scores
of 1,ﬁve indexes had deﬁcit scores of 2, two indexes had deﬁcit scores
of 3, and three indexes had deﬁcit scores of 5. The GDS of BNR is 2.25.For CNR patients, T scores ranged from T=37.1 to 53.4 across the 16
individual indexes. Three cognitive indexes have deﬁcit scores of 1,
and thirteen indexes had deﬁcit scores of 0. The GDS of CNR is 0.19.
4. Discussions
We applied GAP analyses to neurocognitive performance data
from a median sample (n=131) of chronically hospitalized patients
with schizophrenia. The GAP analyses revealed the existence of two
patient subtypes. The post hoc test using the independence t-test
showed that there were signiﬁcant differences between the two
sub-types except for the CPTd index. Group 1 was characterized by
severe neurocognitive impairments across all cognitive indexes ex-
cept for the CPTd index and was referred to as the BNR subtype; in
contrast, Group 2 displayed relatively better cognitive performance
in comparison to the BNR subtype and was referred to as the CNR
subtype. By means of an investigation of the magnitude of the cogni-
tive domain, for BNR patients, the effect sizes across the seven cogni-
tive domains were all higher than 1 ranging from d = 1.12 to d =
2.39. For CNR patients, the resulting effect sizes across the same cog-
nitive domains were all lower than 1 ranging from d = .18 to d =
Table 1
Descriptive statistics of the 131 subjects sample.
BNR CNR P value BNR CNR P value
Original Data Z-score Data
Sample size 77 54 – 77 54 –
Age 48.73 ± 10.82 44.50 ± 10.73 b0.05a – – –
Education 10.74 ± 2.58 11.67 ± 2.95 N0.05a – – –
Gender (male:female) 49:28 37:17 N0.05b – – –
MCSTp 19.97 ± 14.66 7.04 ± 9.58 b0.001a 4.78 ± 4.07 1.15 ± 2.78 b0.001a
TMb 165.47 ± 20.15 92.24 ± 28.10 b0.001a 2.28 ± 0.46 0.56 ± 0.65 b0.001a
TMa 74.03 ± 17.82 49.37 ± 18.51 b0.001a 3.14 ± 1.30 1.29 ± 1.35 b0.001a
CPTp 5.81 ± 8.26 1.61 ± 3.34 b0.01a 3.27 ± 2.04 1.08 ± 1.96 b0.001a
CPTd .62 ± .44 .60 ± .38 N0.05a 0.26 ± 0.93 0.34 ± 0.85 N0.05a
LGTII 5.66 ± 3.00 7.27 ± 2.77 b0.01a −1.45 ± 1.00 −0.91 ± 0.92 b0.001a
LGT 5.31 ± 3.15 7.53 ± 3.69 b0.001a −1.56 ± 1.05 −0.82 ± 1.23 b0.001a
LGII 4.91 ± 3.02 6.98 ± 3.08 b0.001a −1.70 ± 1.01 −1.01 ± 1.03 b0.001a
LGI 4.89 ± 2.68 7.43 ± 3.12 b0.001a −1.70 ± 0.89 −0.86 ± 1.04 b0.001a
SAVFT 23.27 ± 7.51 31.63 ± 9.46 b0.001a −1.75 ± 0.75 −0.92 ± 0.94 b0.001a
VRI 5.26 ± 2.69 7.29 ± 3.08 b0.001a −1.58 ± 0.90 −0.90 ± 1.03 b0.001a
VRII 5.74 ± 2.14 7.54 ± 2.47 b0.001a −1.42 ± 0.71 −0.82 ± 0.82 b0.001a
DSS 5.83 ± 2.71 8.48 ± 3.26 b0.001a −1.39 ± 0.90 −0.51 ± 1.08 b0.001a
MCSTc 1.85 ± 1.57 4.31 ± 2.23 b0.001a −2.25 ± 0.99 −0.70 ± 1.40 b0.001a
BD 6.39 ± 2.31 9.15 ± 3.03 b0.001a −1.20 ± 0.77 −0.28 ± 1.01 b0.001a
WMI 78.27 ± 10.76 96.91 ± 12.83 b0.001a −1.45 ± 0.72 −0.21 ± 0.86 b0.001a
DS 7.48 ± 2.33 10.80 ± 3.11 b0.001a −0.84 ± 0.78 0.27 ± 1.04 b0.001a
ARI 5.11 ± 1.85 8.13 ± 2.35 b0.001a −1.63 ± 0.62 −0.62 ± 0.78 b0.001a
FSIQ 79.67 ± 10.17 97.78 ± 12.14 b0.001a −1.36 ± 0.68 −0.15 ± .81 b0.001a
INF 6.85 ± 2.06 10.06 ± 3.27 b0.001a −1.05 ± 0.69 0.02 ± 1.09 b0.001a
MMSE 24.84 ± 2.72 27.98 ± 1.50 b0.001a −1.10 ± 1.09 0.15 ± 0.60 b0.001a
a P values were computed based on t test by comparing BNR and CNR.
b P values were computed based on chi-square test by comparing BNR and CNR.
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NP impairment. For CNR patients, the GDS of 0.19, whichwas smaller
than the cutoff of 0.5, reﬂected no NP impairment. These analyses
conﬁrmed the utility of the GAPmethod in elucidating homogeneous
subtypes in patients of Han Chinese ethnicity with schizophrenia,
who were characterized by signiﬁcant differences in neurocognitive
impairment (for example, above a 15-point difference in FSIQ). The
results are consistent with a recent study using MCCB (Heinrichs
et al. 2015).
We also noticed that the aforementioned studies and the current
study all used the cognitive domain strategy. One advantage of the
cognitive domain strategy is that it could reduce the likelihood of
false positive ﬁndings obtainedwith individual putative NP or neuro-
physiological measures (Seidman et al. 2015). In this study, we not-6
-5
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-1
0
1
SZ-BNR
Fig. 2. Proﬁles of cognitive function indexes in CNR and BNRNote. MCSTp=Modiﬁed Card S
Test, A form; CPTp = Continuous Performance Test, perseveration error; CPTd = Continuo
Theme immediate recall; LGII= Logistic delayed recall; LGI= Logistic immediate recall; SAV
recall; VRII =Visual Reproduction delayed recall; DSS= Digit Symbol Substitution Test; MC
Memory Index; DS = Digit Span Test; ARI = Arithmetic Test; FSIQ = Full Scaled IQ; INF =only took the cognitive domain strategy, but also clustered patients
according to their performances on these cognitive domains. We
thought that there was another advantage in doing so: additional
clustering of patients by neurocognitive measures could connect
them to different outcomes in different cultural contexts. This will
help clinical practitioners on the front lines to identify patients by
their outcomes in routine practice works and to provide patients
with suitable examinations, therapy, or care. In summary, by combin-
ing the current study and the study of Heinrichs et al., we found that
the CNR and the BNR could be identiﬁed across different patient pop-
ulations, different neurocognitive measures tools, and different
partitioning groups methods. This implied that these two subtypes
were stable and differential neurocognitive domain proﬁles. Recent-
ly, Meier et al. (2014) found that there is substantial NP decline inSZ-CNR
orting Test, perseveration error; TMb= TrialMaking Test, B form; TMa= TrialMaking
us Performance Test, dprime; LGTII = Logistic Theme delayed recall; LGTI = Logistic
FT= Semantic Association Verbal Fluency Test; VRI=Visual Reproduction immediate
STc =Modiﬁed Card Sorting Test, category; BD= Block Design Test; WMI=Working
Information Test; MMSE = Mini Mental Status Examination.
Table 2
Descriptive statistics of the 55 subjects sample.
CNR BNR P value
Sample size 26 29 –
Age 43.35 ± 5.02 43.93 ± 10.90 N0.05a
Education 12.40 ± 1.96 10.25 ± 1.98 b0.001a
Age at ﬁrst onset 24.30 ± 8.21 20.16 ± 3.74 b0.05a
Duration of illness 19.05 ± 7.94 23.77 ± 9.85 N0.05a
CPZE 885.50 ± 670.53 759.24 ± 723.35 N0.05a
Gender (male:female) 10:16 17:12 N0.05b
Negative symptom score 19.75 ± 5.87 18.76 ± 6.22 N0.05a
Positive symptom score 14.70 ± 7.09 19.97 ± 7.84 b0.05a
General symptom score 34.95 ± 11.25 36.55 ± 8.86 N0.05a
PANSS total score 69.40 ± 22.61 75.28 ± 18.53 N0.05a
Social Function
Withdrawal 4.35 ± 1.60 3.03 ± 1.72 b0.01a
Interpersonal 7.70 ± 1.59 6.72 ± 2.00 N0.05a
Independence-competence 11.10 ± 3.43 8.24 ± 2.52 b0.01a
Independence-performance 10.15 ± 3.73 5.86 ± 3.17 b0.001a
Recreation 11.85 ± 3.80 7.55 ± 3.54 b0.001a
Prosocial 5.70 ± 3.48 2.83 ± 2.74 b0.01a
Employment 6.95 ± 1.99 4.07 ± 2.76 b0.001a
Total 57.80 ± 16.51 38.31 ± 14.81 b0.001a
a P values were computed based on t test by comparing BNR and CNR.
b P values were computed based on chi-square test by comparing BNR and CNR.
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extent and developmental progression of decline vary across mental
functions. One important claim in the study of Meier et al. was that
average to above-average NP test performance in a subset of adults
diagnosedwith schizophrenia cannot be used to infer that NP decline
had not occurred. However, they also proposed a limitation for this
claim, because a relatively small group size prevented them from
conducting an in-depth exploration of heterogeneity in NP decline.
We thought that the fact that this study has an important application
to clear this limitation in the near future, for two reasons: ﬁrst, this
study validated the fact that both CNR and BNR patients all had ame-
diumgroup size; and second,most patients of both groupswere eval-
uated using same tests 3 years ago.Webelieve that the followingdata
analysis will supplement the limitation in the study of Meier et al.
4.1. Strength of the study
There were three strengths in this study. First, taking the cognitive
domain strategy lets researchers select suitable neurocognitive mea-
sures according to their own clinical and cultural contexts. This effec-
tively increased many opportunities for comparison among the
studies on cognitive domain basis in schizophrenia from different-3.00
-2.50
-2.00
-1.50
-1.00
-0.50
0.00
Attention
Working
Memory
Executive
Function
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SZ-CNR
Fig. 3. ES pooled rootmean square by domain. Note: Neurocognitive function indexes togeth
WMI; Executive Function: MCSTc, MCSTp, SAVFT; Verbal Memory: LGI, LGII, LGTI, LGTII; Vis
without used to compose of cognitive domains include BD, INF, DS, ARI, and MMSE.social and cultural contexts. Second, we used the GAP method, which
is a dimension-free statistical visualization method preserving every
single piece of numerical information in the ﬁnal output. By using
GAP analysis, clinical researchers can easily comprehend and summa-
rize every piece of information contained in a study data set (Hwu
et al. 2002). Third, the current study was the ﬁrst paper validated
where therewere both CNR and BNR patients of Han Chinese ethnicity
with schizophrenia. Theseﬁndingswill facilitate development on relat-
ed studies in the same clinical and cultural context in the future.4.2. Limitations
There were two limitations in the present study, both of which
limit the generalizability of the results. The major limitation was on
the diversity of sample. Compared with studies of Leung et al.
(2008) and Heinrichs et al. (2015), there was no normal control
group in the present study. Therefore, we used the normative com-
parison standard strategy (Lezak et al. 2004) to judge the impairment
level of subjects on individualized cognitive measures by comparing
the scores of subjects with reliable norms of Taiwanese normal con-
trols for the measures. The minor limitation was on the assessment
tools of neurocognitive domains. We noticed that many studies
used MCCB as a tool for assessing subjects' neurocognitive domains.
However, there is no Chinese version of the MCCB in Taiwan. In the
future, we hope to compare directly the MCCB with the tools that
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